Cancer research 2000: drug resistance, new targets and drugs in development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer research 2000: drug resistance, new targets and drugs in development

Published:2000-06 Issue:3 Volume:3 Page:133-138
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Broxterman Henk J.,Georgopapadakou Nafsika

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference18 articles.

1. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin;Coleman;Mol Pharmacol,2000

2. Doxorubicin gradients in human breast cancer;Lankelma;Clin Cancer Res,1999

3. pH and drug resistance in tumors;Raghunand;Drug Resistance Updates,2000

4. MDR1 gene expression in primary and advanced breast cancer;Yang;Lab Invest,1999

5. Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743);Erba;Br J Cancer,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of signal transduction in cancer treatment and drug resistance;European Journal of Surgical Oncology (EJSO);2002-09

2. Phenothiazines: potential management of Creutzfeldt–Jacob disease and its variants;International Journal of Antimicrobial Agents;2001-11

3. Cancer research 2001: drug resistance, new targets and drug combinations;Drug Resistance Updates;2001-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP